Publicaciones en las que colabora con María Pilar Garrido López (6)

2024

  1. A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer

    Lung Cancer, Vol. 197

2019

  1. Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

    Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2120-2132

2013

  1. Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: Mature results of the Spanish Lung Cancer Group 0008 study

    Lung Cancer, Vol. 81, Núm. 1, pp. 84-90

2009

  1. Hipopituitarismo secundario debido a metástasis en región hipotalámica de carcinoma microcítico de pulmón

    Endocrinologia y Nutricion, Vol. 56, Núm. 4, pp. 201-204

2002

  1. Ifosfamide and vinorelbine in advanced platinum-resistant ovarian cancer: Excessive toxicity with a potentially active regimen

    Gynecologic Oncology, Vol. 84, Núm. 3, pp. 368-373

1991

  1. Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy: A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam

    Acta Oncologica, Vol. 30, Núm. 5, pp. 623-627